Related Experiment Video
Updated: Feb 10, 2026

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae
Published on: June 13, 2025
Current and future perspectives for levofloxacin in severe Pseudomonas aeruginosa infections
1Antibacterials-Medical Department, GlaxoSmithKline S.p.a, Verona, Italy.
Abstract:
The question of whether levofloxacin includes Pseudomonas aeruginosa in its spectrum of clinical activity is discussed by reviewing the major findings on this issue, mainly those published in Italy. The in vitro activity of levofloxacin against P. aeruginosa is now documented on thousands of strains worldwide. The pharmacodynamic properties of levofloxacin allow for the treatment of pseudomonal infections. The levofloxacin clinical results extrapolated from published studies document the efficacy of levofloxacin in the treatment of infections sustained by P. aeruginosa.
Insights
Levofloxacin demonstrates significant in vitro activity against Pseudomonas aeruginosa. Clinical studies confirm its efficacy in treating infections caused by this bacterium, supporting its use in pseudomonal infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen frequently associated with severe infections.
- The clinical utility of fluoroquinolones, including levofloxacin, against P. aeruginosa remains an important therapeutic consideration.
Purpose of the Study:
- To evaluate the spectrum of clinical activity of levofloxacin against Pseudomonas aeruginosa.
- To synthesize evidence on the efficacy of levofloxacin for P. aeruginosa infections.
Main Methods:
- Review of major findings on levofloxacin's activity against P. aeruginosa, with a focus on Italian publications.
- Analysis of in vitro susceptibility data from thousands of strains globally.
- Examination of published clinical results documenting treatment outcomes.
Main Results:
- Levofloxacin exhibits documented in vitro activity against a wide range of P. aeruginosa strains.
- The pharmacodynamic profile of levofloxacin supports its use in treating infections caused by this pathogen.
- Extrapolated clinical data confirm the effectiveness of levofloxacin in treating P. aeruginosa-sustained infections.
Conclusions:
- Levofloxacin possesses a spectrum of activity that includes Pseudomonas aeruginosa.
- The drug is effective for treating infections caused by P. aeruginosa.
- Evidence supports the clinical use of levofloxacin for pseudomonal infections.
Related Concept Videos
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Electrical Current

